Mycronic Full Year 2024 Earnings: Beats Expectations

Mycronic (STO:MYCR) Full Year 2024 Results

Key Financial Results

• Revenue: kr7.06b (up 24% from FY 2023).
• Net income: kr1.68b (up 69% from FY 2023).
• Profit margin: 24% (up from 18% in FY 2023). The increase in margin was driven by higher revenue.
• EPS: kr17.25 (up from kr10.22 in FY 2023).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Mycronic Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) also surpassed analyst estimates by 11%.

The primary driver behind last 12 months revenue was the Pattern Generators (PG) segment contributing a total revenue of kr3.00b (42% of total revenue). The largest operating expense was Research & Development (R&D) costs, amounting to kr747.0m (37% of total expenses). Explore how MYCR's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Electronic industry in Sweden.

Performance of the Swedish Electronic industry.

The company's shares are down 12% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on Mycronic's balance sheet health.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.